PITTSBURGH, Sept. 16,
2024 /PRNewswire/
-- Viatris Inc. (NASDAQ: VTRS) will report its third
quarter 2024 financial results on Thursday,
November 7, 2024, before the open of the U.S. financial
markets. Chief Executive Officer Scott
A. Smith and other Company executives will host a
webcast at 8:30 a.m. ET on the same date to discuss the
results.
Investors and the general public are invited to listen to a live
webcast of the call at investor.viatris.com or by calling
844.308.3344 or 412.317.1896 for international callers. A replay of
the webcast also will be available on the website.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global
healthcare company uniquely positioned to bridge the traditional
divide between generics and brands, combining the best of both to
more holistically address healthcare needs globally. With a mission
to empower people worldwide to live healthier at every stage of
life, we provide access at scale, currently supplying high-quality
medicines to approximately 1 billion patients around the world
annually and touching all of life's moments, from birth to the end
of life, acute conditions to chronic diseases. With our
exceptionally extensive and diverse portfolio of medicines, a
one-of-a-kind global supply chain designed to reach more people
when and where they need them, and the scientific expertise to
address some of the world's most enduring health challenges, access
takes on deep meaning at Viatris. We are headquartered in the U.S.,
with global centers in Pittsburgh,
Shanghai and Hyderabad, India. Learn more at
viatris.com and investor.viatris.com, and connect with us on
LinkedIn, Instagram, YouTube and X (formerly
Twitter).
View original content to download
multimedia:https://www.prnewswire.com/news-releases/viatris-to-report-third-quarter-2024-financial-results-on-november-7-2024-302249244.html
SOURCE Viatris Inc.